For the year ending 2025-12-31, DXCM made $4,662M in revenue. $836.3M in net income. Net profit margin of 17.94%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | 4,662 | 4,033 | 3,622.3 | 2,909.8 |
| Cost of sales | 1,860.1 | 1,594.8 | 1,333.4 | 1,026.7 |
| Gross profit | 2,801.9 | 2,438.2 | 2,288.9 | 1,883.1 |
| Research and development | 599.1 | 552.4 | 505.8 | 484.2 |
| Collaborative research and development fee | - | - | 0 | 0 |
| Amortization of intangible assets | - | - | - | 7.5 |
| Selling, general and administrative | 1,291 | 1,285.8 | 1,185.4 | 1,000.2 |
| Total operating expenses | 1,890.1 | 1,838.2 | 1,691.2 | 1,491.9 |
| Operating income | 911.8 | 600 | 597.7 | 391.2 |
| Interest expense | - | - | - | 18.6 |
| Loss on extinguishment of debt | - | - | - | 0 |
| Income from equity investments | - | - | - | 0.2 |
| Other income, net | 176.6 | 109 | 112.7 | 18 |
| Income before income taxes | 1,088.4 | 709 | 710.4 | 390.8 |
| U.s. federal statutory rate | 228.6 | - | - | - |
| State and local income tax, net of federal income tax effect | 16.4 | - | - | - |
| Foreign rate differential-IE | 63.6 | - | - | - |
| Changes in valuation allowance-IE | -74.5 | - | - | - |
| Other-IE | 5.8 | - | - | - |
| Foreign rate differential-MY | -14.8 | - | - | - |
| Other-MY | 8.9 | - | - | - |
| Foreign rate differential-Foreign Tax Jurisdiction Other | 6.7 | - | - | - |
| Effect of cross-border taxes | 3 | - | - | - |
| Research and development credits | 13.6 | - | - | - |
| Changes in valuation allowance | 0.4 | - | - | - |
| Stock and officers compensation | 16.1 | - | - | - |
| Other | 2.5 | - | - | - |
| Changes in unrecognized tax benefits | 4.4 | - | - | - |
| Other | -1.4 | - | - | - |
| Income tax expense | 252.1 | 132.8 | 168.9 | 49.6 |
| Net income | 836.3 | 576.2 | 541.5 | 341.2 |
| Basic net income per share (in usd per share) | 2.14 | 1.46 | 1.4 | 0.88 |
| Diluted net income per share (in usd per share) | 2.09 | 1.42 | 1.3 | 0.82 |
| Shares used to compute basic net income per share (in shares) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 |
| Shares used to compute diluted net income per share (in shares) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 |
DEXCOM INC (DXCM)
DEXCOM INC (DXCM)